Coronary Artery Disease Clinical Trials in Rochester, Minnesota

4 studies are recruiting for coronary artery disease in Rochester, Minnesota right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Product Surveillance Registry

    The purpose of the Registry is to provide continuing evaluation and periodic reporting of safety and effectiveness of Medtronic market-released products. The Registry data is intended to benefit and support interests of patients, hospitals, clinicians, regulatory bodies, payers, and industry by str…

    Stage
    Not phased
    Ages
    Any age
    Site
    Research site, Rochester, Minnesota
    Locations
    401 in total
    Run by
    Medtronic

    See if you can join NCT01524276 on ClinicalTrials.gov

  2. Influence of Pulse Electromagnetic Field Therapy on Myocardial Ischemia

    This study is being done to observe the effects of treatment from a device called the Bioboosti which utilizes pulsed electromagnetic waves on its ability to improve blood flow to the heart tissue in individuals with coronary artery disease (CAD).

    Stage
    Not phased
    Ages
    18 and older
    Site
    Mayo Clinic in Rochester, Rochester, Minnesota
    Locations
    2 in total
    Run by
    Mayo Clinic

    See if you can join NCT05111288 on ClinicalTrials.gov

  3. CTSN Embolic Protection Trial

    This is a prospective, multi-center, randomized effectiveness trial of the CardioGard Embolic Protection Cannula in high-risk valve surgery patients.

    Stage
    Not phased
    Ages
    60 and older
    Site
    Mayo Clinic, Rochester, Minnesota
    Locations
    28 in total
    Run by
    Icahn School of Medicine at Mount Sinai

    See if you can join NCT06027788 on ClinicalTrials.gov

  4. The Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy Trial (STICH3C)

    The Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy (STICH3C) trial is a prospective, unblinded, international multi-center randomized trial of 754 subjects enrolled in approximately 45 centers comparing revascularization by percutaneous coronary intervention (PCI) vs. coronary artery…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Mayo Clinic, Rochester, Minnesota
    Locations
    43 in total
    Run by
    Sunnybrook Health Sciences Centre

    See if you can join NCT05427370 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.